Ocumension Therapeutics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	402.46	769.21	1,054	1,314	1,785
Cash & Short-Term Investments	402.46	769.21	1,054	1,314	1,785
Cash Growth	-47.68%	-27.01%	-19.83%	-26.37%	-12.99%
Accounts Receivable	323.14	124.26	119.36	112.71	18.51
Other Receivables	16.48	39.81	-	-	25.84
Receivables	339.62	164.07	119.36	112.71	44.35
Inventory	63.92	45.52	32.47	24.1	4.99
Other Current Assets	145.04	-	-	3.9	-
Total Current Assets	951.04	978.8	1,206	1,455	1,835
Property, Plant & Equipment	456.61	451.53	467.65	448.07	365.86
Long-Term Investments	9.07	12.93	364.15	95	272.4
Other Intangible Assets	2,601	2,438	1,140	919.05	709.97
Other Long-Term Assets	73.43	92.43	93.39	126.4	148.25
Total Assets	4,091	3,974	3,271	3,044	3,331
Accounts Payable	68.33	34.42	25.19	21.7	4.41
Accrued Expenses	56.09	44.66	100.35	140.94	89.04
Short-Term Debt	-	-	120	-	-
Current Portion of Long-Term Debt	52.17	2.06	-	-	-
Current Portion of Leases	10.22	6.84	12.33	12.29	4.19
Current Income Taxes Payable	0.03	1.04	0.34	1.55	2.4
Current Unearned Revenue	2.83	7.59	9.05	-	-
Other Current Liabilities	67.09	58.4	48.02	71.18	115.82
Total Current Liabilities	256.76	155	315.28	247.65	215.85
Long-Term Debt	106.04	14.49	-	-	-
Long-Term Leases	19.11	2.39	5.66	17.29	7.03
Long-Term Unearned Revenue	28.3	28.3	30.09	30.09	-
Total Liabilities	410.21	200.19	351.03	295.04	222.88
Common Stock	0.06	0.06	0.05	0.05	0.05
Additional Paid-In Capital	8,947	8,844	7,626	7,511	7,355
Retained Earnings	-5,020	-4,876	-4,722	-4,447	-4,045
Treasury Stock	-0	-0	-0	-0	-0
Comprehensive Income & Other	-245.77	-194.51	15.95	-315.8	-202.79
Total Common Equity	3,681	3,774	2,920	2,749	3,108
Shareholders' Equity	3,681	3,774	2,920	2,749	3,108
Total Liabilities & Equity	4,091	3,974	3,271	3,044	3,331
Total Debt	187.54	25.78	137.98	29.58	11.21
Net Cash (Debt)	214.93	743.42	915.82	1,285	1,774
Net Cash Growth	-71.09%	-18.82%	-28.72%	-27.57%	-13.23%
Net Cash Per Share	0.27	1.09	1.41	2.03	2.92
Filing Date Shares Outstanding	815.38	815.73	690.66	688.74	618.42
Total Common Shares Outstanding	815.38	815.73	690.66	688.74	618.42
Working Capital	694.28	823.79	890.35	1,208	1,619
Book Value Per Share	4.51	4.63	4.23	3.99	5.03
Tangible Book Value	1,080	1,335	1,780	1,830	2,398
Tangible Book Value Per Share	1.32	1.64	2.58	2.66	3.88
Machinery	409.22	394.82	383.13	93.79	10.1
Construction In Progress	95.77	93.56	86.22	323.86	336.98
Leasehold Improvements	15.61	15.21	13.49	9.55	3.61

Source: S&P Global Market Intelligence. Standard template. Financial Sources.